πŸ‡ΊπŸ‡Έ FDA
Patent

US 9227933

3-phenoxymethylpyrrolidine compounds

granted A61KA61K31/40A61K45/06

Quick answer

US patent 9227933 (3-phenoxymethylpyrrolidine compounds) held by Theravance Biopharma R&D IP, LLC expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/40, A61K45/06, A61P, A61P13/00